Conference Papers
Year :
Isabelle COMBE : Connect in order to contact the contributor
https://amu.hal.science/hal-02463220
Submitted on : Friday, January 31, 2020-5:58:23 PM
Last modification on : Friday, March 24, 2023-2:53:14 PM
Dates and versions
Identifiers
- HAL Id : hal-02463220 , version 1
Cite
A Awada, J Harding, Nuria Kotecki, P Aftimos, T. Decaens, et al.. Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Sep 2019, Barcelona, Spain. pp.286. ⟨hal-02463220⟩
11
View
0
Download